Chaturvedi, A., Pusch, S., Stichel, D., Bochtler, T., Ho, A. D., Deimling, A. v., . . . Krämer, A. (2017). Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo. Leukemia, 31(10), . https://doi.org/10.1038/leu.2017.46
Chicago-Zitierstil (17. Ausg.)Chaturvedi, Anuhar, Stefan Pusch, Damian Stichel, Tilmann Bochtler, Anthony Dick Ho, Andreas von Deimling, Karsten Rippe, und Alwin Krämer. "Pan-mutant-IDH1 Inhibitor BAY1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia in Vivo." Leukemia 31, no. 10 (2017). https://doi.org/10.1038/leu.2017.46.
MLA-Zitierstil (9. Ausg.)Chaturvedi, Anuhar, et al. "Pan-mutant-IDH1 Inhibitor BAY1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia in Vivo." Leukemia, vol. 31, no. 10, 2017, https://doi.org/10.1038/leu.2017.46.